These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction. Green J, Banks E, Berrington A, Darby S, Deo H, Newton R. Br J Cancer; 2000 Aug; 83(3):412-7. PubMed ID: 10917561 [Abstract] [Full Text] [Related]
5. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Lilla C, Verla-Tebit E, Risch A, Jäger B, Hoffmeister M, Brenner H, Chang-Claude J. Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594 [Abstract] [Full Text] [Related]
6. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10. Cascorbi I, Roots I, Brockmöller J. Cancer Res; 2001 Jul 01; 61(13):5051-6. PubMed ID: 11431340 [Abstract] [Full Text] [Related]
9. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Nyberg F, Hou SM, Hemminki K, Lambert B, Pershagen G. Cancer Epidemiol Biomarkers Prev; 1998 Oct 01; 7(10):875-83. PubMed ID: 9796632 [Abstract] [Full Text] [Related]
11. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. Alberg AJ, Daudt A, Huang HY, Hoffman SC, Comstock GW, Helzlsouer KJ, Strickland PT, Bell DA. Cancer Detect Prev; 2004 Oct 01; 28(3):187-93. PubMed ID: 15225898 [Abstract] [Full Text] [Related]
12. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Hsieh FI, Pu YS, Chern HD, Hsu LI, Chiou HY, Chen CJ. Br J Cancer; 1999 Oct 01; 81(3):537-41. PubMed ID: 10507782 [Abstract] [Full Text] [Related]
13. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Zhou W, Liu G, Thurston SW, Xu LL, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. Cancer Epidemiol Biomarkers Prev; 2002 Jan 01; 11(1):15-21. PubMed ID: 11815396 [Abstract] [Full Text] [Related]
14. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, Placidi D, Carta A, Hautefeuille A, Boffetta P, Porru S. Cancer Epidemiol Biomarkers Prev; 2003 Nov 01; 12(11 Pt 1):1234-40. PubMed ID: 14652287 [Abstract] [Full Text] [Related]
16. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls. Hou SM, Fält S, Yang K, Nyberg F, Pershagen G, Hemminki K, Lambert B. Cancer Epidemiol Biomarkers Prev; 2001 Feb 01; 10(2):133-40. PubMed ID: 11219770 [Abstract] [Full Text] [Related]